Patrys Ltd
ASX:PAB
Patrys Ltd
ASX:PAB
Price:
0.009 AUD
Market Closed
Updated:
Apr 30, 2024
Section:
Relative Value
The Relative Value of one
PAB
stock under the Base Case scenario is
0.01
AUD.
Compared to the current market price of 0.009 AUD,
Patrys Ltd
is
Undervalued by 12%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PAB
Relative Value
Base Case
0.01
AUD
Undervaluation 12%
Valuation Multiples
Multiples Across Competitors
PAB Competitors Multiples
Patrys Ltd Competitors
Patrys Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Patrys Ltd
ASX:PAB
|
18.5m AUD | 10.9 | -3.6 | -2.7 | -2.7 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
286.8B USD | 5.3 | 59.5 | 12.9 | 19.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
146.6B USD | 5.2 | 21.8 | 16.3 | 24.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
101.8B USD | 10.3 | 28.1 | 22.4 | 23.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
97.7B USD | 7.5 | 24.7 | 16.3 | 18 | |
| AU |
|
CSL Ltd
ASX:CSL
|
133.7B AUD | 6.2 | 35.5 | 21.5 | 26.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
81.3B USD | 3 | 14.4 | 7.9 | 10.2 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
42.5B USD | 6.2 | -9 | -9.5 | -8.1 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
31.4B USD | 3.2 | 27.1 | 14.6 | 18.1 | |
| KR |
|
Celltrion Inc
KRX:068270
|
39.2T KRW | 18 | 73.1 | 44.7 | 61.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
